Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial

NCT02406781 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT02406781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02406781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial
Lead sponsor
Institut Bergonié
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2015
Completion date
January 15, 2023
Enrollment
129 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma